Form 4: Electromed Director Gregory Fluet Acquires 3,000 Shares of Restricted Stock

Director Gregory Fluet acquired 3,000 shares of Electromed, Inc. restricted stock on December 1, 2024, scheduled to vest on June 1, 2025.

Summary

• Gregory Fluet, a director at Electromed, Inc., acquired 3,000 shares of restricted common stock on December 1, 2024.
• The shares were acquired at a price of $0.
• These shares are scheduled to vest on June 1, 2025, unless vesting is accelerated or terminated earlier.
• Following this transaction, Mr. Fluet beneficially owns 18,000 shares of Electromed stock.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of a stock transaction by a company director. It is neither particularly positive nor negative, but the acquisition of shares by a director is generally viewed as a neutral to slightly positive sign.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a standard SEC Form 4 filing, which is common for company insiders when they acquire or dispose of company stock. It is a routine disclosure and does not indicate any specific industry trend.

Comparison to Industry Standards

• SEC Form 4 filings are a standard practice for publicly traded companies in the United States.
• The acquisition of restricted stock by directors is a common form of compensation and incentive in many companies, including those in the medical device industry like Electromed.
• The vesting schedule of June 1, 2025, is a typical vesting period for restricted stock grants.

Stakeholder Impact

• The acquisition of shares by a director may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Electromed, Director, Gregory Fluet, Restricted Stock, Share Acquisition, Beneficial Ownership, SEC Form 4